- Home
- CIM vs MPLT Comparison
CIM vs MPLT Comparison
Compare CIM & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIM | MPLT |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 822.2M |
| IPO Year | 2007 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CIM | MPLT |
|---|---|---|
| Price | $12.48 | $17.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $15.25 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 823.7K | 378.8K |
| Earning Date | 02-11-2026 | 12-04-2025 |
| Dividend Yield | ★ 11.67% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $191,573,000.00 | N/A |
| Revenue This Year | $11.44 | N/A |
| Revenue Next Year | $21.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.85 | $12.24 |
| 52 Week High | $15.37 | $21.55 |
Technical Indicators
Market Signals| Indicator | CIM | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 44.43 | N/A |
| Support Level | $12.30 | N/A |
| Resistance Level | $12.81 | N/A |
| Average True Range (ATR) | 0.25 | 0.00 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 26.03 | 0.00 |
Price Performance
Historical ComparisonAbout CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About MPLT MapLight Therapeutics Inc.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.